QHSLabs, Inc.

QHSLabs, Inc. Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from QHSLabs, Inc., Business service, 901 Northpoint Parkway Suite 302, West Palm Beach, FL.

We are a medical device technology company that equips primary care physicians (PCPs) with the digital solutions needed to increase their practice revenues through value-based tools that evaluate and treat chronic disease.

QHSLab Inc. (OTCQB: USAQ) has released an unaudited financial and operational update ahead of its January 2026 investor ...
01/06/2026

QHSLab Inc. (OTCQB: USAQ) has released an unaudited financial and operational update ahead of its January 2026 investor session. 📊

Highlights include:
âś… $1.99M in revenue for the 9 mo. ended 9/30/25 (+32% YoY)
âś… ~66% gross margin
âś… Positive operating income before interest
âś… Convertible debt reduced from ~$1.4M to ~$20K
âś… ~$630K cash on hand entering 2026

With a simplified balance sheet and reduced interest expense, management believes the Company is well-positioned for improved operating leverage in 2026 and is focused on further enhancing profitability and supporting continued growth throughout the year.

Read the full release here: https://www.qhslab.com/press-releases/qhslab-otcqb-usaq-issues-unaudited-financial-and-operational-update-ahead-of-january-2026-investor-session.




Over the past year, QHSLab has been very deliberate about strengthening the foundation of the business before pushing ha...
12/30/2025

Over the past year, QHSLab has been very deliberate about strengthening the foundation of the business before pushing harder on growth.

This recent equity investment was about simplifying our balance sheet, improving liquidity, and creating breathing room to execute. It was not about short-term optics or financial engineering. It was about putting the company in a better position to do the work that actually matters, supporting our customers, expanding utilization, and building a durable business.

We also wanted to be thoughtful about how capital comes into the company. This was a clean market transaction with no brokers, no commissions, and no toxic structures. The investors involved spent time doing real diligence and invested with a long-term view.

Just as important, this step does not change our broader plans. We remain focused on disciplined ex*****on, responsible governance, and aligning with partners who see QHSLab as a long-term platform.

Progress is rarely one big moment. It’s a series of small, intentional steps taken in the right order. This was one of those steps.

Read the release here: https://www.qhslab.com/press-releases/qhslab-inc-otcqb-usaq-completes-500k-private-placement-enters-2026-with-clean-capital-structure

12/09/2025

Early cognitive and functional decline is happening far more often than we catch in routine primary care. đź§ 

That’s why we built Q-Cog™ — a whole-person, biopsychosocial cognitive assessment that actually captures what traditional visits miss.

Our first real-world data is in:
➡️ 72% of adults screened had measurable cognitive concerns
➡️ 76% reported functional limitations
➡️ Falls risk + SDoH are compounding vulnerability

This is the future of proactive, whole-person care — and the early findings say it’s overdue.

Read more here: https://www.qhslab.com/learning-lab/blog/from-dr-ms-desk-early-real-world-findings-from-the-q-cog-tm-biopsychosocial-assessment

12/08/2025

Dr. Patricia Junquera, Chair of Psychiatric Behavioral Health and Associate Professor at FIU HWCOM, joins QHS to share how to identify cognitive impairment at the primary care level.

“Revenue growth is accelerating, gross margins are expanding, and the balance sheet has been significantly strengthened....
12/08/2025

“Revenue growth is accelerating, gross margins are expanding, and the balance sheet has been significantly strengthened.”

This week, we announced the Q-Cog™, a comprehensive, cloud-based cognitive assessment built to help primary care provide...
12/04/2025

This week, we announced the Q-Cog™, a comprehensive, cloud-based cognitive assessment built to help primary care providers identify Mild Cognitive Impairment (MCI) and dementia-related risks earlier in the disease process.

Q-Cog™ unifies validated cognitive, behavioral, and functional screening into one seamless digital workflow, helping clinicians meet CMS screening guidelines while supporting risk adjustment and reimbursement under neurocognitive and behavioral health codes.

In an initial real-world pilot among 168 patients aged 65 and older, Q-Cog™ identified 90 individuals (54%) at high risk for cognitive impairment and facilitated real-time telemedicine referrals—underscoring the significant unmet need for early detection in primary care. Despite national guidelines, more than 50% of Mild Cognitive Impairment cases and up to 60–80% of dementia cases go unrecognized during routine visits.

This persistent diagnostic gap, driven by time pressures and limited tools, leaves many patients undetected until functional decline is apparent. Q-Cog™ bridges this gap by delivering a fast, structured, digital assessment that enables primary-care clinicians to identify risk earlier and initiate timely, evidence-based follow-up.

Read the full release here: https://www.qhslab.com/press-releases/qhslab-otcqb-usaq-announces-launch-of-q-cog-tm-to-support-early-detection-of-mild-cognitive-impairment-and-dementia

From all of us at QHSLab, Happy Thanksgiving! 🧡
11/27/2025

From all of us at QHSLab, Happy Thanksgiving! 🧡

ICYMI: Our latest webinar replay is now available!Primary care plays a critical role in identifying early signs of Mild ...
11/21/2025

ICYMI: Our latest webinar replay is now available!

Primary care plays a critical role in identifying early signs of Mild Cognitive Impairment (MCI) and dementia.

Watch Dr. Patricia Junquera, Chair of Psychiatric Behavioral Health at FIU HWCOM, share practical tools PCPs can use to recognize cognitive impairment sooner and intervene effectively.

👉 Watch the replay: https://www.qhslab.com/learning-lab/webinars/tools-to-identify-cognitive-impairment-at-the-primary-care-level-a-conversation-with-a-psychiatrist

FOR IMMEDIATE RELEASE: QHSLab (OTCQB: USAQ) Strengthens Balance Sheet & Delivers Strong Q3 2025 Results QHSLab has offic...
11/18/2025

FOR IMMEDIATE RELEASE: QHSLab (OTCQB: USAQ) Strengthens Balance Sheet & Delivers Strong Q3 2025 Results

QHSLab has officially repurchased and retired over $1.4M in legacy convertible debt, eliminating a major source of dilution risk and significantly improving our capital structure. This strategic move removes the $0.20/share conversion overhang, reduces over $200K in annualized interest expense, and positions us for stronger long-term growth.

From CEO Troy Grogan:
“Eliminating this legacy debt strengthens our financial position, reduces dilution risk, and supports our long-term growth strategy as we continue advancing digital medicine for primary care.”

Read the full release here: https://www.qhslab.com/press-releases/qhslab-otcqb-usaq-completes-repurchase-of-legacy-debt-enhancing-capital-structure-strengthening-balance-sheet-and-reducing-future-dilution
$USAQ

Address

901 Northpoint Parkway Suite 302
West Palm Beach, FL
33407

Alerts

Be the first to know and let us send you an email when QHSLabs, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to QHSLabs, Inc.:

Share